Supplementation with Selenium yeast on the prooxidant-antioxidant activities and anti-tumor effects in breast tumor xenograft-bearing mice

Journal of Nutritional Biochemistry

Volumn 26, Issue 12, 2015, Pages 1568-1579

  Guo, Chih Hung ^a,b,c,d   Hsia, Simon ^a,d   Hsiung, Der Yun ^a,g   Chen, Pei Chung ^d,e,f  

^a HUNGKUANG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d Taiwan Medical Association   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^g NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Breast cancer; Mice; Oxidative stress; Selenium yeast

Indexed keywords

GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; INTERLEUKIN 2; INTERLEUKIN 4; MALONALDEHYDE; PROTEIN BCL 2; PROTEIN P53; SELENIUM; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CYTOKINE; OXIDIZING AGENT; OXYGEN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; BREAST TUMOR; CANCER INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; FOOD INTAKE; LIPID PEROXIDATION; MOUSE; NONHUMAN; ONCOGENE; OXIDATION; OXIDATIVE STRESS; SELENIUM YEAST; SINGLE DRUG DOSE; SUPPLEMENTATION; TH1 CELL; TH2 CELL; TUMOR XENOGRAFT; YEAST; ANIMAL; BAGG ALBINO MOUSE; BREAST NEOPLASMS; CHEMISTRY; CYTOLOGY; DIETARY SUPPLEMENT; DRUG SCREENING; INFLAMMATION; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; BODY WEIGHT; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOKINES; DIETARY SUPPLEMENTS; FEMALE; GLUTATHIONE PEROXIDASE; INFLAMMATION; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; OXIDANTS; OXIDATIVE STRESS; OXYGEN; REACTIVE OXYGEN SPECIES; SELENIUM; TH1 CELLS; TH2 CELLS; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS; YEASTS;

EID: 84983203490     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.07.028     Document Type: Article

References (48)

1. Lee K.D., Chen S.C., Chan C.H., Lu C.H., Chen C.C., Lin J.T., et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev 2008, 17:2647-2655.
2. Donadio A.C., Lobo C., Tosina M., de la Rosa V., Martín-Rufián M., Campos-Sandoval J.A., et al. Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells. J Cell Biochem 2008, 103:800-811.
3. Guo C.H., Hsia S., Chen P.C. Distribution of selenium and oxidative stress in breast tumor-bearing mice. Nutrients 2013, 5:594-607.
4. Hardbower D.M., de Sablet T., Chaturvedi R., Wilson K.T. Chronic inflammation and oxidative stress: The smoking gun for Helicobacter pylori-induced gastric cancer?. Gut Microbes 2013, 4:475-481.
5. Pervin S., Tran L., Urman R., Braga M., Parveen M., Li S.A., et al. Oxidative stress specifically down regulates survivin to promote breast tumour formation. Br J Cancer 2013, 108:848-858.
6. Fang Y.Z., Yang S., Wu G. Free radicals, antioxidants, and nutrition. Nutrition 2002, 18:872-879.
7. Arthur J.R., McKenzie R.C., Beckett G.J. Selenium in the immune system. J Nutr 2003, 133(5 Suppl. 1):1457S-1459S.
8. Ravn-Haren G., Olsen A., Tjønneland A., Dragsted L.O., Nexø B.A., Wallin H., et al. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 2006, 27:820-825.
9. Franca C.A., Nogueira C.R., Ramalho A., Carvalho A.C., Vieira S.L., Penna A.B. Serum levels of selenium in patients with breast cancer before and after treatment of external beam radiotherapy. Ann Oncol 2011, 22:1109-1112.
10. Zhang S., Li F., Younes M., Liu H., Chen C., Yao Q. Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium. PLoS One 2013, 8:e63702.
11. Yazdi M.H., Mahdavi M., Kheradmand E., Shahverdi A.R. The preventive oral supplementation of a selenium nanoparticle-enriched probiotic increases the immune response and lifespan of 4 T1 breast cancer bearing mice. Arzneimittelforschung 2012, 62:525-531.
12. Chen Y.C., Prabhu K.S., Das A., Mastro A.M. Dietary selenium supplementation modifies breast tumor growth and metastasis. Int J Cancer 2013, 133:2054-2064.
13. Lu J., Jiang C. Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells. Antioxid Redox Signal 2005, 7:1715-1727.
14. Brozmanová J., Mániková D., Vlčková V., Chovanec M. Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol 2010, 84:919-938.
15. Drake E.N. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Med Hypotheses 2006, 67:318-322.
16. Halasi M., Pandit B., Wang M., Nogueira V., Hay N., Gartel A.L. Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth. Am J Pathol 2013, 183:257-265.
17. Wang H., Chan Y.L., Li T.L., Bauer B.A., Hsia S., Wang C.H., et al. Reduction of splenic immunosuppressive cells and enhancement of anti-tumor immunity by synergy of fish oil and selenium yeast. PLoS One 2013, 8(1):e52912.
18. Guo C.H., Wang C.L. Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients. Int J Med Sci 2013, 10:79-89.
19. Rayman M.P. The use of high-selenium yeast to raise selenium status: how does it measure up?. Br J Nutr 2004, 92:557-573.
20. Jacobson G.K. Dietary selenium and selenized yeast. Agro Food Industry Hi Tech 2010, 21(n4):14-16.
21. Longnecker M.P., Stram D.O., Taylor P.R., Levander O.A., Howe M., Veillon C., et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology 1996, 7:384-390.
22. Nakayama A., Hill K.E., Austin L.M., Motley A.K., Burk R.F. All regions of mouse brain are dependent on selenoprotein P for maintenance of selenium. J Nutr 2007, 137:690-693.
23. Tapiero H., Townsend D.M., Tew K.D. The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 2003, 57:134-144.
24. Yadav N.K., Poudel B., Thanpari C., Chandra Koner B. Assessment of biochemical profiles in premenopausal and postmenopausal women with breast cancer. Asian Pac J Cancer Prev 2012, 13:3385-3388.
25. Charalabopoulos K., Kotsalos A., Batistatou A., Charalabopoulos A., Vezyraki P., Peschos D., et al. Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA. Br J Cancer 2006, 95:674-676.
26. Wrobel J.K., Seelbach M.J., Chen L., Power R.F., Toborek M. Supplementation with selenium-enriched yeast attenuates brain metastatic growth. Nutr Cancer 2013, 65:563-570.
27. Hussain S.P., Hofseth L.J., Harris C.C. Radical causes of cancer. Nat Rev Cancer 2003, 3:276-285.
28. Tuzcu M., Sahin N., Ozercan I., Seren S., Sahin K., Kucuk O. The effects of selenium supplementation on the spontaneously occurring fibroid tumors of oviduct, 8-hydroxy-2- deoxyguanosine levels, and heat shock protein 70 response in Japanese quail. Nutr Cancer 2010, 62:495-500.
29. Harris H.R., Bergkvist L., Wolk A. Selenium intake and breast cancer mortality in a cohort of Swedish women. Breast Cancer Res Treat 2012, 134:1269-1277.
30. Charalabopoulos K., Kotsalos A., Batistatou A., Charalabopoulos A., Peschos D., Vezyraki P., et al. Serum and tissue selenium levels in gastric cancer patients and correlation with CEA. Anticancer Res 2009, 29:3465-3467.
31. Serewko M.M., Popa C., Dahler A.L., Smith L., Strutton G.M., Coman W., et al. Alterations in gene expression and activity during squamous cell carcinoma development. Cancer Res 2002, 62:3759-3765.
32. Jardim B.V., Moschetta M.G., Leonel C., Gelaleti G.B., Regiani V.R., Ferreira L.C., et al. Glutathione and glutathione peroxidase expression in breast cancer: An immunohistochemical and molecular study. Oncol Rep 2013, 30:1119-1128.
33. Reagan-Shaw S., Nihal M., Ahsan H., Mukhtar H., Ahmad N. Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio. Prostate 2008, 68:1624-1634.
34. Song R.X., Zhang Z., Mor G., Santen R.J. Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells. Apoptosis 2005, 10:667-678.
35. Lee Y.S., Kang Y.S., Lee S.H., Kim J.A. Role of NAD(P)H oxidase in the tamoxifen-induced generation of reactive oxygen species and apoptosis in HepG2 human hepatoblastoma cells. Cell Death Differ 2000, 7:925-932.
36. McLaughlin R., O'Hanlon D., McHale T., Connolly C.E., Given H.F. Prognostic implications of p53 and bcl-2expression in 108 women with stage two breast cancer. Ir J Med Sci 2001, 170:11-13.
37. Liang Y., Besch-Williford C., Hyder S.M. PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein. Int J Oncol 2009, 35:1015-1023.
38. Macip S., Igarashi M., Berggren P., Yu J., Lee S.W., Aaronson S.A. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 2003, 23:8576-8585.
39. Pani G., Galeotti T., Chiarugi P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 2010, 29:351-378.
40. Jiang C., Jiang W., Ip C., Ganther H., Lu J. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinog 1999, 26:213-225.
41. Goto S., Sato M., Kaneko R., Itoh M., Sato S., Takeuchi S. Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients. Cancer Immunol Immunother 1999, 48:435-442.
42. Soliman H. Immunotherapy strategies in the treatment of breast cancer. Cancer Control 2013, 20:17-21.
43. + T cells in tumor immunity. ISRN Immunol 2011, 2011. 10.5402/2011/497397.
44. Rogers K.M., Thomas M., Galligan L., Wilson T.R., Allen W.L., Sakai H., et al. Cellular FLICE-inhibitory protein regulates chemotherapy-induced apoptosis in breast cancer cells. Mol Cancer Ther 2007, 6:1544-1551.
45. Roy M., Kiremidjian-Schumacher L., Wishe H., Cohen M.W., Stotzky G. Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol Trace Elem Res 1994, 41:103-114.
46. Al-Ghurabi B.H. IL-2 and IL-4 serum levels in breast cancer. J Fac Med Baghdad 2009, 51:300-303.
47. Murta E.F., de Andrade J.M., Falcão R.P., Bighetti S. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumor 2000, 86:403-407.
48. Nagai S., Toi M. Interleukin-4 and breast cancer. Breast Cancer 2000, 7:181-186.